Search results
Results From The WOW.Com Content Network
Data from the Australian Institute of Health and Welfare shows that out-of-pocket payments increased four-and-a-half times faster than government funding in 2014–15. [62] This has led to large numbers of patients skipping treatment or medicine. [63] Australian out-of-pocket health expenses are the third highest in the developed world. [62] [1]
Prisoners on average are less healthy and have higher rates of chronic illnesses, infectious diseases, aquired brain injuries and drug use than the general community. [4] [5] People entering prison typically come from extremely disadvantaged backgrounds, and may have under-utilised health care prior to entering custody, [6] as health was viewed as a lower priority than issues including housing ...
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Cerebrovascular diseases can have a significant social impact on its survivors. [4] Stroke is a chronic condition and it negatively affects stroke survivors’ capabilities in social interactions and community participation. [19] The carers of stroke survivors also often experience a decrease in the extent to which their own needs are being met ...
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
For premium support please call: 800-290-4726 more ways to reach us
Myelosuppression, pleural effusion, seizures, tumour lysis syndrome and a condition similar to Guillain-Barré syndrome. Pentostatin: IV: Adenosine deaminase inhibitor. Hairy cell leukaemia, peripheral T-cell lymphoma (orphan), cutaneous T cell lymphoma (orphan) and chronic lymphocytic leukaemia (orphan).
In 1944, the Curtin Labor government passed the Pharmaceutical Benefits Act 1944 [1] [2] as part of a wider plan to create a British-style National Health Service.The Act was an extension of the similar Repatriation Pharmaceutical Benefits Scheme established in 1919 for Australian servicemen and women who had served in the Boer War and World War I.